N,N-DIETHYL-2-(2-HYDROXY-2,2-DIPHENYLACETOXY)-N-METHYLETHANAMINIUM BROMIDE, 95%, 25g

6-Chloro-3,4-dimethoxypyridazine, 95%, 1g

3-([1,1'-Biphenyl]-4-yl)-2-aminopropanoic acid, 95.0%, 5g

2-(2-((Benzo[d]1,3-dioxolan-5-ylamino)sulfonyl)-4,5-dimethoxyphenyl)acetic acid, 95%, 1g

4-(Pyren-1-yl)butanoic acid, 95.0%, 100g

3-(Tritylthio)propanoic Acid>97.0%(HPLC)(T)25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((bis(methylamino)methylene)amino)pentanoic acid, 97%, 5g

(R)-tert-Butyl 3-(pyridin-2-yloxy)pyrrolidine-1-carboxylate, 95.0%, 100mg

4-(6-Chloropyrimidin-4-yl)-N-methylthiazol-2-amine, 95.0%, 1g

Ethyl 3-oxohept-6-enoate, 95%, 5g

3-(METHYLSULFONYL)PIPERIDINE HCL, 95.0%, 5g

3-(((5-Chloro-3-ethylpyrazolo[1,5-a]pyrimidin-7-yl)amino)methyl)pyridine 1-oxide, 95%, 100mg

2-(4-Piperidinyl)propanoic acid hydrochloride, 95.0%, 5g